ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q1SCImago #906Top JournalHybrid

Diabetes

Abbreviation (ISO):DIABETES
•
Identifier (ISSN):0012-1797(Print)/1939-327X(Online)
•
Publisher:American Diabetes Association Inc.
Clarivate IF (2026)
9.3↑ +1.8
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIETop Tier
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Diabetes

WoS Q1
4710137.2720187.220197.7220209.4620219.3420227.720236.220247.520259.32026
Annual Impact Factor Metric
Current (2026):9.3
Scopus SJR & RankScopus Q1
2.613
#906

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
388

388 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate1.6%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
244articles/year
2.49% Gold OA•100% Original Research

Aims & Scope

Diabetes publishes original research about the physiology and pathophysiology of diabetes mellitus. Submitted manuscripts can report any aspect of laboratory, animal, or human research. Emphasis is on investigative reports focusing on areas such as the pathogenesis of diabetes and its complications, normal and pathologic pancreatic islet function and intermediary metabolism, pharmacological mechanisms of drug and hormone action, and biochemical and molecular aspects of normal and abnormal biological processes. Studies in the areas of diabetes education or the application of accepted therapeutic and diagnostic approaches to patients with diabetes mellitus are not published.

Topics Covered (Recognized by AI)
Medicine98%Biology92.2%Endocrinology88%Internal medicine86.2%Diabetes mellitus73%Chemistry61.8%Biochemistry58.6%Biotechnology52.7%Insulin51.9%Genetics50.9%Pathology43.4%Obesity23.4%Gene21.9%Type 2 diabetes21.7%Physics21.1%

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

ENDOCRINOLOGY & METABOLISM

Q1
Rank13/198
IndexSCIE
JCISCIE2026

ENDOCRINOLOGY & METABOLISM

Q1
Rank23/198
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF9.3
Articles / Year2,318
Total Citations112
2025
IF7.5
Articles / Year2,474
Total Citations1,323
2024
IF6.2
Articles / Year2,313
Total Citations2,799
2023
IF7.7
Articles / Year2,298
Total Citations3,790
2022
IF9.337
Articles / Year2,012
Total Citations6,969

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #906Scopus Q1SCImago Profile
Scopus Coverage:1952-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q1
2.613

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
5.41

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,966 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations3,623
3-Year Documents629
Citable Documents548

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate43.9%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Endocrinology, Diabetes and MetabolismQ1
Internal MedicineQ1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 1.6%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
2区 (Zone 2)Medicine
Minor Category (Specific Field):
1区ENDOCRINOLOGY & METABOLISM
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Diabetes (abbr: DIABETES, ISSN: 0012-1797) is a peer-reviewed international scholarly journal in the field of Medicine, published by American Diabetes Association Inc. in United States since 1952. The periodical holds a Journal Impact Factor (JIF) of 9.30, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 2.613 (Q1), an H-index of 388.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 244 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,966 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
American Diabetes Association Inc.
Publication Language
English
Frequency
Monthly
Founding Year
1952
Indexing & Databases
SCIEScopusPubMed
Editorial Address
AMER DIABETES ASSOC, 1701 N BEAUREGARD ST, ALEXANDRIA, USA, VA, 22311-1717

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 4bd0e865-617d-4f0a-a319-ec68f68ac16c
Database Updated: 2026-10-01